214 related articles for article (PubMed ID: 35338580)
1. Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes.
Sahana S; Sivadas A; Mangla M; Jain A; Bhoyar RC; Pandhare K; Mishra A; Sharma D; Imran M; Senthivel V; Divakar MK; Rophina M; Jolly B; Batra A; Sharma S; Siwach S; Jadhao AG; Palande NV; Jha GN; Ashrafi N; Mishra PK; Vidhya AK; Jain S; Dash D; Kumar NS; Vanlallawma A; Sarma RJ; Chhakchhuak L; Kalyanaraman S; Mahadevan R; Kandasamy S; Devi P; Rajagopal RE; Ramya JE; Devi PN; Bajaj A; Gupta V; Mathew S; Goswami S; Prakash S; Joshi K; Kumla M; Sreedevi S; Gajjar D; Soraisham R; Yadav R; Devi YS; Gupta A; Mukerji M; Ramalingam S; Binukumar BK; Sivasubbu S; Scaria V
Pharmacogenomics; 2021 Jul; 22(10):603-618. PubMed ID: 34142560
[No Abstract] [Full Text] [Related]
3. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
4. Population structure and pharmacogenomic risk stratification in the United States.
Nagar SD; Conley AB; Jordan IK
BMC Biol; 2020 Oct; 18(1):140. PubMed ID: 33050895
[TBL] [Abstract][Full Text] [Related]
5. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
6. Genetic epidemiology of pharmacogenetic variants in South East Asian Malays using whole-genome sequences.
Sivadas A; Salleh MZ; Teh LK; Scaria V
Pharmacogenomics J; 2017 Oct; 17(5):461-470. PubMed ID: 27241059
[TBL] [Abstract][Full Text] [Related]
7. A Comprehensive Analysis of 21 Actionable Pharmacogenes in the Spanish Population: From Genetic Characterisation to Clinical Impact.
Nunez-Torres R; Pita G; Peña-Chilet M; López-López D; Zamora J; Roldán G; Herráez B; Álvarez N; Alonso MR; Dopazo J; Gonzalez-Neira A
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111771
[TBL] [Abstract][Full Text] [Related]
8. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
10. Preemptive Pharmacogenomic Testing for Precision Medicine: A Comprehensive Analysis of Five Actionable Pharmacogenomic Genes Using Next-Generation DNA Sequencing and a Customized CYP2D6 Genotyping Cascade.
Ji Y; Skierka JM; Blommel JH; Moore BE; VanCuyk DL; Bruflat JK; Peterson LM; Veldhuizen TL; Fadra N; Peterson SE; Lagerstedt SA; Train LJ; Baudhuin LM; Klee EW; Ferber MJ; Bielinski SJ; Caraballo PJ; Weinshilboum RM; Black JL
J Mol Diagn; 2016 May; 18(3):438-445. PubMed ID: 26947514
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomic survey of Qatari populations using whole-genome and exome sequences.
Sivadas A; Scaria V
Pharmacogenomics J; 2018 Jul; 18(4):590-600. PubMed ID: 29720721
[TBL] [Abstract][Full Text] [Related]
12. Phenotype prediction and characterization of 25 pharmacogenes in Thais from whole genome sequencing for clinical implementation.
Mauleekoonphairoj J; Chamnanphon M; Khongphatthanayothin A; Sutjaporn B; Wandee P; Poovorawan Y; Nademanee K; Pongpanich M; Chariyavilaskul P
Sci Rep; 2020 Nov; 10(1):18969. PubMed ID: 33144648
[TBL] [Abstract][Full Text] [Related]
13. Population Diversity in Pharmacogenetics: A Latin American Perspective.
Suarez-Kurtz G; Parra EJ
Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
[TBL] [Abstract][Full Text] [Related]
14. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
Maisano Delser P; Fuselli S
Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
[TBL] [Abstract][Full Text] [Related]
15. Fetal pharmacogenomics: A promising addition to complex neonatal care.
Raymond M; Critchlow E; Rice SM; Wodoslawsky S; Berger SI; Hegde M; Empey PE; Al-Kouatly HB
Mol Genet Metab; 2022; 137(1-2):140-145. PubMed ID: 36029725
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics at Scale: An Analysis of the UK Biobank.
McInnes G; Lavertu A; Sangkuhl K; Klein TE; Whirl-Carrillo M; Altman RB
Clin Pharmacol Ther; 2021 Jun; 109(6):1528-1537. PubMed ID: 33237584
[TBL] [Abstract][Full Text] [Related]
17. Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry.
Mbavha BT; Kanji CR; Stadler N; Stingl J; Stanglmair A; Scholl C; Wekwete W; Masimirembwa C
Pharmacogenet Genomics; 2022 Jul; 32(5):173-182. PubMed ID: 35190514
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse Populations.
Luo S; Jiang R; Grzymski JJ; Lee W; Lu JT; Washington NL
Clin Pharmacol Ther; 2021 Sep; 110(3):759-767. PubMed ID: 33930192
[TBL] [Abstract][Full Text] [Related]
19. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
Caspar SM; Schneider T; Meienberg J; Matyas G
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
[TBL] [Abstract][Full Text] [Related]
20. Characterization of pharmacogenomic variants in a Brazilian admixed cohort of elderly individuals based on whole-genome sequencing data.
Bertholim-Nasciben L; Scliar MO; Debortoli G; Thiruvahindrapuram B; Scherer SW; Duarte YAO; Zatz M; Suarez-Kurtz G; Parra EJ; Naslavsky MS
Front Pharmacol; 2023; 14():1178715. PubMed ID: 37234706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
